Clinical trials: Major Cardiovascular Event

Myocarditis

Incidence, Patient Characteristics and Outcome of Myocarditis After COVID-19 mRNA Vaccine

• Completed
• Age: 16 to 65 years
• Observational study
• Vaccines

This study evaluates the incidence, patient characteristics and outcome of myocarditis after the COVID-19 mRNA vaccination in healthcare professionals.

Trial name

MACIS (NCT05438472)

Testing

data collection in healthcare professionals with COVID-19 mRNA vaccine booster

Where

Switzerland

Volunteers

835 people, healthy volunteers welcome

Sponsor

University Hospital, Basel, Switzerland